The unique combination of electrophysiological techniques will allow us to investigate the (dys)function of the whole peripheral motor system and the contribution of the different parts to the clinical phenotype in SMN2-splicing modifying treatment-naïve children above 12 years, adolescents, and adults with SMA types 1–4. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.